Advocates for AIDS research and treatment agree. A press release issued by the Elizabeth Glaser Pediatric AIDS Foundation stressed the importance of preserving single-dose nevirapine as an option: “Even simple interventions like nevirapine are still available to less than 10% of the women who need them worldwide. Therefore, we must continue to aggressively expand access to services and improve our ability to offer the most effective drug regimens in all instances.”
News
Nevirapine Monotherapy Needs to Be Reassessed : Giving HIV+women multidrug regimens in late pregnancy may do more to reduce virus transmission.
Publish date: May 1, 2005
